美國居民不適用 XM 服務。

Agrochemicals company Syngenta posts big drop in Q1 sales, earnings



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Agrochemicals company Syngenta posts big drop in Q1 sales, earnings</title></head><body>

Adds details, background

ZURICH, April 29 (Reuters) -Seeds and pesticides maker Syngenta suffered big drops in first quarter sales and profit, the company said on Monday, just a few weeks after the Swiss company shelved its plans for a $10 billion flotation.

Sales fell 20% to $7.4 billion, Syngenta said, while core operating profit (EBITDA) declined by 34% to $1.2 billion, as farmers continued to run down their supplies rather than buying new seeds and sprays.

Higher interest rates were causing destocking by retailers and distributors, Syngenta said, with the crop protection business hardest hit with sales down 20%.

The seeds business meanwhile reported sales down 8%, said the Chinese-owned company that competes with U.S. company Corteva CTVA.N, as well as Germany's BASF BASFn.DE and Bayer BAYGn.DE.

Syngenta in March withdrew its bid for a multi-billion dollar listing on the Shanghai Stock Exchange amid a period of weakness in the Chinese equity market.

The initial public offering (IPO), which would have valued the Sinochem owned company at as much as $60 billion, has been postponed repeatedly since being proposed in 2021 due to unfavourable market conditions.

Syngenta said in March it will restart the listing process in China or elsewhere "when the conditions are right" while also looking into alternate sources of funding.



Reporting by John Revill, Editing by Friederike Heine

</body></html>

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明